CA Stock MarketDetailed Quotes

NARA PanGenomic Health Inc

Watchlist
  • 0.160
  • +0.015+10.34%
15min DelayMarket Closed Dec 27 09:53 ET
1.02MMarket Cap-0.01P/E (TTM)

PanGenomic Health Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
113.48%15.35K
83.75%-59.53K
102.09%15.59K
43.65%-1.57M
6.04%-341.21K
90.70%-113.86K
36.49%-366.41K
-20.79%-746.59K
-162.69%-2.78M
53.11%-363.15K
Net income from continuing operations
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Operating gains losses
--0
----
----
-1,491.29%-36.35K
-7,202.30%-37.07K
95.23%-108
176.38%734
-75.42%103
---2.28K
--522
Depreciation and amortization
-32.46%2.11K
0.00%3.13K
3.47%3.13K
11.60%12.4K
5.29%3.13K
7.94%3.13K
14.93%3.13K
19.64%3.02K
422.47%11.11K
39.63%2.97K
Asset impairment expenditure
--0
----
----
-99.02%82.04K
-99.55%37.34K
--8.46K
----
----
366.05%8.36M
--8.36M
Remuneration paid in stock
144.05%32.05K
-60.88%34.07K
-36.90%38.88K
-73.04%166.3K
-54.74%90.37K
-133.86%-72.77K
29.77%87.09K
-54.40%61.61K
1,112.31%616.79K
416.91%199.67K
Change In working capital
-30.19%178.87K
-67.21%153.4K
-22.10%192.34K
424.52%1.18M
-52.10%209.47K
158.31%256.23K
188.89%467.86K
278.79%246.9K
186.90%225.05K
300.59%437.32K
-Change in receivables
379.13%12.53K
-100.15%-61
-137.43%-1.61K
171.26%66.73K
348.20%24.92K
86.62%-4.49K
284.32%42.01K
115.74%4.29K
-125.18%-93.64K
54.04%-10.04K
-Change in prepaid assets
--0
-97.54%3.03K
130.82%3.16K
159.33%197.91K
-82.34%31.75K
125.74%53.12K
127.22%123.29K
-121.07%-10.24K
127.80%76.32K
172.04%179.77K
-Change in payables and accrued expense
-19.88%166.34K
-50.28%150.43K
-24.55%190.79K
277.85%915.82K
-42.90%152.8K
204.06%207.6K
131.89%302.56K
477.00%252.86K
324.03%242.38K
401.41%267.59K
Cash from discontinued investing activities
Operating cash flow
113.48%15.35K
83.75%-59.53K
102.09%15.59K
43.65%-1.57M
6.04%-341.21K
90.70%-113.86K
36.49%-366.41K
-20.79%-746.59K
-162.69%-2.78M
53.11%-363.15K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
93.97%-3.14K
0
0
0
-109.61%-3.14K
91.38%-52.13K
-839.77%-46.12K
Net PPE purchase and sale
--0
--0
--0
47.68%-3.14K
--0
--0
--0
-109.61%-3.14K
11.87%-6.01K
--0
Net business purchase and sale
----
----
----
--0
----
----
----
----
-237.49%-46.12K
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
93.97%-3.14K
--0
--0
--0
-109.61%-3.14K
91.38%-52.13K
-839.77%-46.12K
Financing cash flow
Cash flow from continuing financing activities
0
-87.06%45.28K
0
-5.04%1.5M
-27.35%341.22K
126.4K
-68.32%350K
677.62K
-47.06%1.57M
931.97%469.68K
Net issuance payments of debt
--0
-86.57%47K
--0
581.94%964.4K
146.59%448.92K
-88.56%126.4K
--350K
--39.08K
607.11%141.42K
---963.48K
Net common stock issuance
--0
---1.72K
--0
-84.22%203.62K
-108.34%-107.7K
--0
--0
--311.32K
-47.47%1.29M
71,132.36%1.29M
Proceeds from stock option exercised by employees
--0
--0
--0
129.63%327.22K
--0
--0
--0
--327.22K
--142.5K
--142.5K
Cash from discontinued financing activities
Financing cash flow
--0
-87.06%45.28K
--0
-5.04%1.5M
-27.35%341.22K
--126.4K
-68.32%350K
--677.62K
-47.06%1.57M
931.97%469.68K
Net cash flow
Beginning cash position
277,940.00%13.9K
71.49%28.15K
-85.81%12.56K
-93.44%88.53K
-55.39%12.54K
-100.00%5
-97.75%16.41K
-93.44%88.53K
3,427.93%1.35M
-98.65%28.12K
Current changes in cash
22.46%15.35K
13.18%-14.25K
121.62%15.59K
93.97%-75.97K
-99.97%17
101.02%12.54K
-103.12%-16.41K
88.36%-72.11K
-196.16%-1.26M
108.23%60.41K
End cash Position
133.25%29.26K
277,940.00%13.9K
71.49%28.15K
-85.81%12.56K
-85.81%12.56K
-55.39%12.54K
-100.00%5
-97.75%16.41K
-93.44%88.53K
-93.44%88.53K
Free cash from
113.48%15.35K
83.75%-59.53K
102.08%15.59K
43.66%-1.57M
6.04%-341.21K
90.72%-113.86K
36.71%-366.41K
-21.00%-749.73K
-161.58%-2.79M
53.52%-363.15K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 113.48%15.35K83.75%-59.53K102.09%15.59K43.65%-1.57M6.04%-341.21K90.70%-113.86K36.49%-366.41K-20.79%-746.59K-162.69%-2.78M53.11%-363.15K
Net income from continuing operations 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Operating gains losses --0---------1,491.29%-36.35K-7,202.30%-37.07K95.23%-108176.38%734-75.42%103---2.28K--522
Depreciation and amortization -32.46%2.11K0.00%3.13K3.47%3.13K11.60%12.4K5.29%3.13K7.94%3.13K14.93%3.13K19.64%3.02K422.47%11.11K39.63%2.97K
Asset impairment expenditure --0---------99.02%82.04K-99.55%37.34K--8.46K--------366.05%8.36M--8.36M
Remuneration paid in stock 144.05%32.05K-60.88%34.07K-36.90%38.88K-73.04%166.3K-54.74%90.37K-133.86%-72.77K29.77%87.09K-54.40%61.61K1,112.31%616.79K416.91%199.67K
Change In working capital -30.19%178.87K-67.21%153.4K-22.10%192.34K424.52%1.18M-52.10%209.47K158.31%256.23K188.89%467.86K278.79%246.9K186.90%225.05K300.59%437.32K
-Change in receivables 379.13%12.53K-100.15%-61-137.43%-1.61K171.26%66.73K348.20%24.92K86.62%-4.49K284.32%42.01K115.74%4.29K-125.18%-93.64K54.04%-10.04K
-Change in prepaid assets --0-97.54%3.03K130.82%3.16K159.33%197.91K-82.34%31.75K125.74%53.12K127.22%123.29K-121.07%-10.24K127.80%76.32K172.04%179.77K
-Change in payables and accrued expense -19.88%166.34K-50.28%150.43K-24.55%190.79K277.85%915.82K-42.90%152.8K204.06%207.6K131.89%302.56K477.00%252.86K324.03%242.38K401.41%267.59K
Cash from discontinued investing activities
Operating cash flow 113.48%15.35K83.75%-59.53K102.09%15.59K43.65%-1.57M6.04%-341.21K90.70%-113.86K36.49%-366.41K-20.79%-746.59K-162.69%-2.78M53.11%-363.15K
Investing cash flow
Cash flow from continuing investing activities 00093.97%-3.14K000-109.61%-3.14K91.38%-52.13K-839.77%-46.12K
Net PPE purchase and sale --0--0--047.68%-3.14K--0--0--0-109.61%-3.14K11.87%-6.01K--0
Net business purchase and sale --------------0-----------------237.49%-46.12K----
Cash from discontinued investing activities
Investing cash flow --0--0--093.97%-3.14K--0--0--0-109.61%-3.14K91.38%-52.13K-839.77%-46.12K
Financing cash flow
Cash flow from continuing financing activities 0-87.06%45.28K0-5.04%1.5M-27.35%341.22K126.4K-68.32%350K677.62K-47.06%1.57M931.97%469.68K
Net issuance payments of debt --0-86.57%47K--0581.94%964.4K146.59%448.92K-88.56%126.4K--350K--39.08K607.11%141.42K---963.48K
Net common stock issuance --0---1.72K--0-84.22%203.62K-108.34%-107.7K--0--0--311.32K-47.47%1.29M71,132.36%1.29M
Proceeds from stock option exercised by employees --0--0--0129.63%327.22K--0--0--0--327.22K--142.5K--142.5K
Cash from discontinued financing activities
Financing cash flow --0-87.06%45.28K--0-5.04%1.5M-27.35%341.22K--126.4K-68.32%350K--677.62K-47.06%1.57M931.97%469.68K
Net cash flow
Beginning cash position 277,940.00%13.9K71.49%28.15K-85.81%12.56K-93.44%88.53K-55.39%12.54K-100.00%5-97.75%16.41K-93.44%88.53K3,427.93%1.35M-98.65%28.12K
Current changes in cash 22.46%15.35K13.18%-14.25K121.62%15.59K93.97%-75.97K-99.97%17101.02%12.54K-103.12%-16.41K88.36%-72.11K-196.16%-1.26M108.23%60.41K
End cash Position 133.25%29.26K277,940.00%13.9K71.49%28.15K-85.81%12.56K-85.81%12.56K-55.39%12.54K-100.00%5-97.75%16.41K-93.44%88.53K-93.44%88.53K
Free cash from 113.48%15.35K83.75%-59.53K102.08%15.59K43.66%-1.57M6.04%-341.21K90.72%-113.86K36.71%-366.41K-21.00%-749.73K-161.58%-2.79M53.52%-363.15K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.